Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis.
作者信息
Murphy E A, Bell A L, Wojtulewski J, Brzeski M, Madhok R, Capell H A
机构信息
University Department of Medicine, Glasgow Royal Infirmary.
出版信息
BMJ. 1994 Nov 19;309(6965):1337-8. doi: 10.1136/bmj.309.6965.1337.
Abstract
摘要
相似文献
1
Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis.促红细胞生成素治疗类风湿关节炎患者贫血的研究。
BMJ. 1994 Nov 19;309(6965):1337-8. doi: 10.1136/bmj.309.6965.1337.
2
Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin.类风湿关节炎贫血对皮下注射重组人促红细胞生成素治疗的反应
Ann Rheum Dis. 1992 Jun;51(6):747-52. doi: 10.1136/ard.51.6.747.
3
Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease.
J Rheumatol. 1991 Aug;18(8):1168-71.
4
[Erythropoietin--therapeutic option in chronic polyarthritis-induced anemia].
Z Rheumatol. 1995 Jan-Feb;54(1):50-5.
5
Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies.
Arthritis Rheum. 1989 May;32(5):638-42. doi: 10.1002/anr.1780320519.
6
Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.通过血清促红细胞生成素检测监测慢性肾衰竭贫血的促红细胞生成素治疗。
Ann Clin Biochem. 1993 Mar;30 ( Pt 2):205-6. doi: 10.1177/000456329303000219.
7
Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis.
Am J Med. 1990 Aug;89(2):161-8. doi: 10.1016/0002-9343(90)90294-n.
8
The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia.重组人促红细胞生成素对类风湿关节炎贫血患者自体献血的影响。
Clin Exp Rheumatol. 1999 Jan-Feb;17(1):69-74.
9
引用本文的文献
1
[Preoperative anemia in patients with rheumatic diseases].[风湿性疾病患者的术前贫血]
Z Rheumatol. 2022 Apr;81(3):205-211. doi: 10.1007/s00393-021-01146-5. Epub 2022 Jan 28.
2
Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.用于类风湿关节炎贫血的促红细胞生成素
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD000332. doi: 10.1002/14651858.CD000332.pub3.
3
Burden of anemia in patients with osteoarthritis and rheumatoid arthritis in French secondary care.法国二级保健中骨关节炎和类风湿关节炎患者的贫血负担。
BMC Geriatr. 2010 Aug 26;10:59. doi: 10.1186/1471-2318-10-59.
4
Quality of life in patients with rheumatoid arthritis : which drugs might make a difference?类风湿关节炎患者的生活质量：哪些药物可能会产生影响？
Pharmacoeconomics. 2003;21(13):927-40. doi: 10.2165/00019053-200321130-00002.
5
Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.重组人促红细胞生成素对类风湿性关节炎合并慢性病贫血患者贫血及疾病活动的影响：一项随机、安慰剂对照、双盲、为期52周的临床试验
Ann Rheum Dis. 1996 Oct;55(10):739-44. doi: 10.1136/ard.55.10.739.
6
Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications.阿法依泊汀。其药效学和药代动力学特性以及在非肾脏应用中的治疗用途综述。
Drugs. 1995 Feb;49(2):232-54. doi: 10.2165/00003495-199549020-00008.
7
Rheumatology.风湿病学
BMJ. 1995 Mar 11;310(6980):637-40. doi: 10.1136/bmj.310.6980.637.
8
Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.促红细胞生成素α。关于其在治疗与肾衰竭和慢性病相关的贫血中的临床疗效及其在外科手术患者中的应用的综述。
Drugs Aging. 1995 Aug;7(2):131-56. doi: 10.2165/00002512-199507020-00007.
本文引用的文献
1
2
Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis.
Am J Med. 1990 Aug;89(2):161-8. doi: 10.1016/0002-9343(90)90294-n.
3
Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin.类风湿关节炎贫血对皮下注射重组人促红细胞生成素治疗的反应
Ann Rheum Dis. 1992 Jun;51(6):747-52. doi: 10.1136/ard.51.6.747.
Zotero 插件